Day: March 20, 2024

Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2024

Written by Customer Service on March 20, 2024. Posted in Earnings Releases And Operating Results.

AI demand and tight supply accelerate return to profitability BOISE, Idaho, March 20, 2024 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced results for its second quarter of fiscal 2024, which ended February 29, 2024. Fiscal Q2 2024 highlightsRevenue of $5.82 billion versus $4.73 billion for the prior quarter and $3.69 billion for the same period last yearGAAP net income of $793 million, or $0.71 per diluted share Non-GAAP net income of $476 million, or $0.42 per diluted share Operating cash flow of $1.22 billion versus $1.40 billion for the prior quarter and $343 million for the same period last year“Micron delivered fiscal Q2 results with revenue, gross margin and EPS well above the high-end of our guidance range — a testament to our team’s excellent execution on pricing, products and operations,”...

Steelcase Reports Fourth Quarter and Fiscal 2024 Results

Written by Customer Service on March 20, 2024. Posted in Earnings Releases And Operating Results.

Fourth quarter resultsOrders grew 4% compared to prior year driven by 8% growth in the Americas Gross margin improved 140 basis points compared to prior year Earnings per share increased 38% compared to prior yearFiscal 2024 resultsGross margin improved 360 basis points compared to fiscal 2023 Earnings per share increased 127% compared to fiscal 2023 Total liquidity strengthened by $238 million during fiscal 2024Company provides financial targets for fiscal 2025GRAND RAPIDS, Mich., March 20, 2024 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) today reported fourth quarter revenue of $775.2 million, net income of $21.3 million, or $0.18 per share, and adjusted earnings per share of $0.23. In the prior year, Steelcase reported revenue of $801.7 million, net income of $15.7 million, or $0.13 per share, and adjusted...

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Written by Customer Service on March 20, 2024. Posted in Earnings Releases And Operating Results.

– Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) – – Announced Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist – – Cash runway extended into 2025 – – Conference call and webcast today at 4:30 p.m. ET / 1:30 p.m. PT – SAN JOSE, Calif., March 20, 2024 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter and full year ended December 31, 2023 and provided a corporate update. “We have kicked off 2024 with positive momentum announcing positive topline results from our Phase 1 study for RT-111, which serves...

Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Written by Customer Service on March 20, 2024. Posted in Earnings Releases And Operating Results.

Trem-cel and VCAR33ALLO clinical trial data expected in the second half of 2024 VCAR33ALLO granted Fast Track and Orphan Drug Designation by U.S. Food & Drug Administration Cash runway extends into second half of 2025CAMBRIDGE, Mass., March 20, 2024 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period and full year ended December 31, 2023, and provided a business update. “We are very pleased with the foundational progress we made in 2023. Building on this, we expect 2024 to be an exciting year in which we demonstrate the Vor Bio approach to be instrumental in reducing the disease burden of AML, a devastating cancer where we desperately need effective treatment options,” said Dr. Robert Ang, Vor Bio’s President and Chief...

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Written by Customer Service on March 20, 2024. Posted in Earnings Releases And Operating Results.

Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024 Randomized Phase 2 Study of 171 Second-Line Colorectal Cancer Patients Fully Recruited Anticipated Cash Runway into 2025 EDINBURGH, United Kingdom, March 20, 2024 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the fourth quarter and year ended December 31, 2023 and provided an update on its broad clinical development program with its transformative ProTide therapeutics. As of December 31, 2023, NuCana had cash and cash equivalents of £17.2 million compared to £17.8 million as of September 30, 2023 and £41.9 million as of December 31, 2022. NuCana continues to advance its various clinical programs and reported a net...

Nanophase Reports Fourth Quarter and Year End 2023 Results, New Financing Package

Written by Customer Service on March 20, 2024. Posted in Earnings Releases And Operating Results.

— Delivered $37.3 million in full year revenue— Closed on $6 million financing— Won 2024 Cosmetics and Toiletries Allē Award Finished Formula Prestige Category ROMEOVILLE, Ill., March 20, 2024 (GLOBE NEWSWIRE) — Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the fourth quarter and fiscal year ended December 31, 2023.  Jess Jankowski, President and Chief Executive Officer, commented: “2023 started out with strong first and second quarters, and while the third and fourth quarters experienced supply chain issues that affected profitability, we ended the year feeling confident...

Five Below, Inc. Announces Fourth Quarter and Fiscal 2023 Financial Results

Written by Customer Service on March 20, 2024. Posted in Earnings Releases And Operating Results.

Q4 Net Sales Increase of 19% with a Comparable Sales Increase of 3.1%; Q4 EPS Increase of 19% Fiscal 2023 Net Sales Increase of 16% with a Comparable Sales Increase of 2.8%; Fiscal 2023 EPS Increase of 15% Provides First Quarter and Fiscal 2024 Guidance PHILADELPHIA, PA, March 20, 2024 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE) today announced financial results for the fourth quarter and full year of fiscal 2023 ended February 3, 2024, both of which contained one additional week (“53rd week”) versus the comparable periods, and outlook for fiscal 2024. For the fourth quarter ended February 3, 2024:Net sales increased by 19.1% to $1.34 billion from $1.12 billion in the fourth quarter of fiscal 2022. Excluding the impact of the 53rd week in fiscal 2023, net sales increased 14.9%; comparable sales increased by...

UMH PROPERTIES, INC. PUBLISHES ITS 2023 ANNUAL REPORT

Written by Customer Service on March 20, 2024. Posted in Public Companies.

FREEHOLD, NJ, March 20, 2024 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), a real estate investment trust (REIT) specializing in manufactured home communities, announced today that it has published its 2023 Annual Report. It is now available on the Company’s website at www.umh.reit. Samuel A. Landy, President and Chief Executive Officer, commented, “We are proud to announce that our 2023 Annual Report is now available on our website. We encourage everyone to read our Annual Report to gain further information on our Company and our future outlook.” UMH Properties, Inc., which was organized in 1968, is a public equity REIT that owns and operates 135 manufactured home communities containing approximately 25,800 developed homesites. These communities are located in New Jersey, New York, Ohio, Pennsylvania, Tennessee,...

The Coretec Group Releases March 2024 Shareholder Call Transcript and Webcast Recording

Written by Customer Service on March 20, 2024. Posted in Public Companies.

The Coretec Group and Core Optics leadership reviewed their pending transaction and detailed the various market opportunities for existing products as well as Endurion ANN ARBOR, Mich., March 20, 2024 (GLOBE NEWSWIRE) — The Coretec Group (OTCQB: CRTG), developers of silicon anode active materials for lithium-ion batteries and cyclohexasilane (CHS) for electric vehicles (EVs), cleantech, and emerging tech applications today released the transcript and webcast recording from its March 14, 2024 shareholder update on the Company’s Investor Relations Website. During the call, The Coretec Group’s Chief Executive Officer, Matthew Kappers, and Chief Operations and Financial Officer, Matthew Hoffman spoke alongside Core Optics, LLC’s Chief Executive Officer, Dr. Seonkee Kim. The group discussed the synergistic alignment resulting from the...

Renewal and appointment on Nexans Board of Directors to be proposed at the Shareholders’ Meeting to be held on May 16th, 2024

Written by Customer Service on March 20, 2024. Posted in Public Companies.

Renewal and appointment on Nexans Board of Directors to be proposed at the Shareholders’ Meeting to be held on May 16th, 2024 _PRESS RELEASE_ La Défense, March 20th, 2024 – Upon recommendation of the Appointments and Corporate Governance Committee, the Nexans Board of Directors has resolved today to propose to the shareholders’ meeting to be held on May 16th, 2024: (i) the renewal of Jane Basson as an independent director and (ii) the appointment of Tamara de Gruyter as an independent director succeeding to Sylvie Jéhanno who is leaving the Board due to her increasing other engagements. In addition, Tamara de Gruyter is appointed Censor, effective today. In such role she will attend all Board of Directors meetings and be bound by the same obligations as directors. Tamara de Gruyter is President Portfolio Business and...

Day: March 20, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice